Mammalian target of rapamycin inhibition after solid organ transplantation: can it, and does it, reduce cancer risk?
about
Chemotherapy and Transplantation: The Role of Immunosuppression in Malignancy and a Review of Antineoplastic Agents in Solid Organ Transplant Recipients.De novo malignancy after lung transplantation in Japan.Matrix metalloproteinases are possible targets in monocrotaline-induced pulmonary hypertension: investigation of anti-remodeling effects of alagebrium and everolimus.
P2860
Mammalian target of rapamycin inhibition after solid organ transplantation: can it, and does it, reduce cancer risk?
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Mammalian target of rapamycin ...... d does it, reduce cancer risk?
@en
type
label
Mammalian target of rapamycin ...... d does it, reduce cancer risk?
@en
prefLabel
Mammalian target of rapamycin ...... d does it, reduce cancer risk?
@en
P2860
P356
P1476
Mammalian target of rapamycin ...... d does it, reduce cancer risk?
@en
P2093
Kymberly D Watt
Mamatha Bhat
P2860
P304
P356
10.1111/CTR.12559
P577
2015-06-10T00:00:00Z